126 related articles for article (PubMed ID: 22520153)
1. Benzothiazoles as probes for the 5HT1A receptor and the serotonin transporter (SERT): a search for new dual-acting agents as potential antidepressants.
Zhu XY; Etukala JR; Eyunni SV; Setola V; Roth BL; Ablordeppey SY
Eur J Med Chem; 2012 Jul; 53():124-32. PubMed ID: 22520153
[TBL] [Abstract][Full Text] [Related]
2. Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Zhou D; Harrison BL; Shah U; Andree TH; Hornby GA; Scerni R; Schechter LE; Smith DL; Sullivan KM; Mewshaw RE
Bioorg Med Chem Lett; 2006 Mar; 16(5):1338-41. PubMed ID: 16332439
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Docking of Novel 3-Indolylpropyl Derivatives as New Polypharmacological Agents Displaying Affinity for 5-HT
Pessoa-Mahana H; Silva-Matus P; Pessoa-Mahana CD; Chung H; Iturriaga-Vásquez P; Quiroz G; Möller-Acuña P; Zapata-Torres G; Saitz-Barría C; Araya-Maturana R; Reyes-Parada M
Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27981607
[TBL] [Abstract][Full Text] [Related]
4. Novel mannich bases, 5-arylimidazolidine-2,4-dione derivatives with dual 5-HT(1A) receptor and serotonin transporter affinity.
Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Siwek A; Bojarski AJ; Bednarski M; Wróbel D; Wesołowska A
Arch Pharm (Weinheim); 2013 Feb; 346(2):98-109. PubMed ID: 23288448
[TBL] [Abstract][Full Text] [Related]
5. Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.
Hatzenbuhler NT; Baudy R; Evrard DA; Failli A; Harrison BL; Lenicek S; Mewshaw RE; Saab A; Shah U; Sze J; Zhang M; Zhou D; Chlenov M; Kagan M; Golembieski J; Hornby G; Lai M; Smith DL; Sullivan KM; Schechter LE; Andree TH
J Med Chem; 2008 Nov; 51(21):6980-7004. PubMed ID: 18834188
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antidepressant evaluation and docking studies of long-chain alkylnitroquipazines as serotonin transporter inhibitors.
Gabrielsen M; Wołosewicz K; Zawadzka A; Kossakowski J; Nowak G; Wolak M; Stachowicz K; Siwek A; Ravna AW; Kufareva I; Kozerski L; Bednarek E; Sitkowski J; Bocian W; Abagyan R; Bojarski AJ; Sylte I; Chilmonczyk Z
Chem Biol Drug Des; 2013 Jun; 81(6):695-706. PubMed ID: 23574807
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.
Andersen J; Stuhr-Hansen N; Zachariassen L; Toubro S; Hansen SM; Eildal JN; Bond AD; Bøgesø KP; Bang-Andersen B; Kristensen AS; Strømgaard K
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12137-42. PubMed ID: 21730142
[TBL] [Abstract][Full Text] [Related]
8. 3-[(Aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter.
Nencetti S; Demontis GC; Mazzoni MR; Betti L; Banti I; Rossello A; Lapucci A
J Pharm Pharmacol; 2007 Oct; 59(10):1439-45. PubMed ID: 17910821
[TBL] [Abstract][Full Text] [Related]
9. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.
Mewshaw RE; Zhou D; Zhou P; Shi X; Hornby G; Spangler T; Scerni R; Smith D; Schechter LE; Andree TH
J Med Chem; 2004 Jul; 47(15):3823-42. PubMed ID: 15239661
[TBL] [Abstract][Full Text] [Related]
10. Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives.
Zhou D; Zhou P; Evrard DA; Meagher K; Webb M; Harrison BL; Huryn DM; Golembieski J; Hornby GA; Schechter LE; Smith DL; Andree TH; Mewshaw RE
Bioorg Med Chem; 2008 Jul; 16(14):6707-23. PubMed ID: 18571421
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a series of benzoxazole/benzothiazole-containing 2,3-dihydrobenzo[b][1,4]dioxine derivatives as potential antidepressants.
Wang S; Chen Y; Zhao S; Xu X; Liu X; Liu BF; Zhang G
Bioorg Med Chem Lett; 2014 Apr; 24(7):1766-70. PubMed ID: 24618300
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT
Wróbel MZ; Chodkowski A; Dawidowski M; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Satała G; Bojarski AJ; Turło J
Bioorg Chem; 2023 Dec; 141():106903. PubMed ID: 37827015
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis.
Ferrés-Coy A; Pilar-Cuellar F; Vidal R; Paz V; Masana M; Cortés R; Carmona MC; Campa L; Pazos A; Montefeltro A; Valdizán EM; Artigas F; Bortolozzi A
Transl Psychiatry; 2013 Jan; 3(1):e211. PubMed ID: 23321808
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.
Perrone R; Berardi F; Colabufo NA; Lacivita E; Larizza C; Leopoldo M; Tortorella V
J Pharm Pharmacol; 2005 Oct; 57(10):1319-27. PubMed ID: 16259761
[TBL] [Abstract][Full Text] [Related]
16. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2.
Herold F; Izbicki Ł; Chodkowski A; Dawidowski M; Król M; Kleps J; Turło J; Wolska I; Nowak G; Stachowicz K; Dybała M; Siwek A; Nowak M; Pieniazek E; Jarończyk M; Sylte I; Mazurek AP
Eur J Med Chem; 2009 Nov; 44(11):4702-15. PubMed ID: 19665823
[TBL] [Abstract][Full Text] [Related]
17. An activity model for novel antidepressants that interact with the serotonin transporter (SERT).
Pissurlenkar RS; Dhir A; Kessar SV; Kulkarni SK; Coutinho EC
Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):228-37. PubMed ID: 21919867
[TBL] [Abstract][Full Text] [Related]
18. Studies towards the next generation of antidepressants. Part 4: derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor.
Evrard DA; Zhou P; Yi SY; Zhou D; Smith DL; Sullivan KM; Hornby GA; Schechter LE; Andree TH; Mewshaw RE
Bioorg Med Chem Lett; 2005 Feb; 15(4):911-4. PubMed ID: 15686885
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function.
Zhao Y; Sun L
J Clin Neurosci; 2008 Nov; 15(11):1264-9. PubMed ID: 18815045
[TBL] [Abstract][Full Text] [Related]
20. Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Venkatesan AM; Dos Santos O; Ellingboe J; Evrard DA; Harrison BL; Smith DL; Scerni R; Hornby GA; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2010 Feb; 20(3):824-7. PubMed ID: 20064720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
